Compounds > caffeine

caffeine and oseltamivir

caffeine has been researched along with oseltamivir in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andricopulo, AD; Moda, TL; Montanari, CA1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Izumi, Y; Narahashi, T; O'Dell, K; Tokuda, K; Zorumski, C1
Guo, Z; He, H; Higgins, D; Li, G; Liu, Y; Liu, Z; Lu, J; Shanahan-Prendergast, L; Walsh, A; Wang, G; Zhang, D1
Eyanagi, R; Imoto, M; Kuroki, H; Nishimura, S; Shimeno, H; Soeda, S; Toda, A; Uchiyama, H; Watanabe, S1
Hiromura, M; Honda, S; Inoue, K; Kosako, K; Kuroki, H; Shiratani, T; Soeda, S; Toda, A; Uchiyama, H1

Reviews

1 review(s) available for caffeine and oseltamivir

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for caffeine and oseltamivir

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Synaptic and behavioral interactions of oseltamivir (Tamiflu) with neurostimulants.
    Human & experimental toxicology, 2008, Volume: 27, Issue:12

    Topics: Animals; Antiviral Agents; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Drug Interactions; Enzyme Inhibitors; Ephedrine; Ethanol; Excitatory Postsynaptic Potentials; Hippocampus; Locomotion; Long-Term Synaptic Depression; Male; Neuraminidase; Oseltamivir; Rats; Rats, Sprague-Dawley; Risk Assessment; Time Factors

2008
Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2009, Oct-08, Volume: 38, Issue:3

    Topics: Animals; Caffeine; Cell Line; Chickens; Dogs; Drug Combinations; Drug Evaluation, Preclinical; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Oseltamivir

2009
The stimulatory effects of caffeine with oseltamivir (Tamiflu) on light-dark behavior and open-field behavior in mice.
    Neuroscience letters, 2010, Jan-22, Volume: 469, Issue:2

    Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Antiviral Agents; Caffeine; Darkness; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Exploratory Behavior; Flumazenil; GABA Modulators; GABA-A Receptor Antagonists; Haloperidol; Male; Mice; Motor Activity; Neurotransmitter Agents; Oseltamivir; Pyrimidines; Random Allocation; Triazoles; Xanthines

2010
Effect of adenosine system in the action of oseltamivir on behavior in mice.
    Neuroscience letters, 2015, Jul-10, Volume: 599

    Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Antiviral Agents; Behavior, Animal; Caffeine; Dose-Response Relationship, Drug; Drug Interactions; Male; Mice; Neuraminidase; Oseltamivir; Phenethylamines; Pyrimidines; Receptors, Adenosine A2; Triazoles; Walking

2015